Biggest News Aggregation in the World
📰 Resented News

Page 32 - Resented News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Resented. Real-time updates on events, politics, business and more.

PEP Health: Ground-breaking Data Presented at HLTH 2022 Highlights 'Real-time' View of Patient Experience of Hospitals in Texas

LAS VEGAS, NV / ACCESSWIRE / November 13, 2022 / New data presented at HLTH 2022 (13-16 November) shows that patient experience of hospitals in Texas have been steadily increasing over the last 4 years.The
Baptist Medical Center United States United Kingdom Kostenloser Wertpapierhandel Alex Griffiths Las Vegas

Cantargia AB: Cantargia's CAN10 demonstrates positive activity in systemic sclerosis models in new data presented at ACR Convergence 2022

Strongly supports therapeutic potential in one of CAN10's lead indications LUND, Sweden, Nov. 8, 2022 /PRNewswire/ -- Cantargia (Cantargia AB) (Nasdaq Stockholm: CANTA) today reported new
United States Prnewswire Cantargia Heinrich Heine University Hiller Research Center Nasdaq Stockholm Systemic Sclerosis Related Disorders

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Data Support the Use of KRYSTEXXA® (pegloticase) Injection with Methotrexate to Treat Uncontrolled Gout in People With Mild-to-Moderate Chronic Kidney Disease

-- MIRROR randomized controlled trial data to be presented during Kidney Week 2022 show consistent kidney function, eGFR levels, for people receiving KRYSTEXXA with methotrexate throughout the... | November 5, 2022
United States Brad Marder Clin Rheumatol Abdul Abdellatif Patients With Uncontrolled Gout Co Exchange Commission

Genmab A/S: Genmab Announces Multiple Abstracts to be Presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH)

Nineteen abstracts accepted, including multiple presentations on the safety and efficacy of investigational epcoritamab (DuoBody-CD3xCD20) in a variety of treatment settings and hematologic malignancies
Al Qahirah United States New Orleans New Jersey David Freundel Epcoritamab Monotherapy

Nutriband Inc.: Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheu

ORLANDO, FL / ACCESSWIRE / October 26, 2022 / Nutriband Inc. (the "Company") (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that its subsidiary, 4P Therapeutics LLC ("4P Therapeutics"), has conducted a Phase
United States Sorrento Sofusa Alan Smith Semnur Pharmaceuticals Inc Drug Administration American College Of Rheumatology

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science